Joel F. Martin
Founder at Dauntless Pharmaceuticals, Inc.
Profile
Joel F.
Martin is the founder of Sofinnova Investments, Inc. (1974) and Dauntless Pharmaceuticals, Inc. (2015).
He held the title of President & Chief Executive Officer at Sofinnova Investments, Inc. and President, Chief Executive Officer & Director at Dauntless Pharmaceuticals, Inc. (current).
Dr. Martin is also the founder of Argonaut Technologies, Inc., Quantum Dot Corp., Intrepida Bio, Inc., and other companies.
Currently, he is the President, Chief Executive Officer & Director at Dauntless 1, Inc. and Dauntless 2, Inc. He previously held the position of President, Chief Executive Officer & Director at Cebix, Inc. and Altair Therapeutics, Inc. He was also a Director at Hypnion, Inc. and a Principal at Institutional Venture Partners.
Dr. Martin's education includes a doctorate from the University of California San Diego and an undergraduate degree and MBA from the University of Michigan.
Joel F. Martin active positions
Companies | Position | Start |
---|---|---|
Dauntless Pharmaceuticals, Inc.
Dauntless Pharmaceuticals, Inc. Drugstore ChainsRetail Trade Dauntless Pharmaceuticals, Inc. develops specialty therapeutics via a one-asset, one-company model that is structured to facilitate operational efficiencies. The company was founded by Joel F. Martin and Michael F. Powell in May 2015 and is headquartered in San Diego, CA. | Founder | 01/05/2015 |
Dauntless 2, Inc.
Dauntless 2, Inc. Pharmaceuticals: MajorHealth Technology Dauntless 2, Inc. operates in the healthcare industry focused on pharmaceutical business. The company is headquartered in San Diego, CA. | Chief Executive Officer | - |
Dauntless 1, Inc.
Dauntless 1, Inc. Pharmaceuticals: MajorHealth Technology Dauntless 1, Inc. engages in pharmaceuticals. The company is headquartered in San Diego, CA. | Chief Executive Officer | - |
Intrepida Bio, Inc.
Intrepida Bio, Inc. Pharmaceuticals: MajorHealth Technology Intrepida Bio, Inc. discovers and develops medicines to modulate the innate immune system to fight cancer and other diseases. The company was founded by Joel F. Martin and Olivier Laurent and is headquartered in San Diego, CA. | Founder | - |
Former positions of Joel F. Martin
Companies | Position | End |
---|---|---|
Altair Therapeutics, Inc.
Altair Therapeutics, Inc. Medical DistributorsDistribution Services Altair is a privately owned company that was spun out of ISIS Pharmaceuticals in October 2007 with the objective of applying ISIS’s proprietary second generation (2’-MOE Gapmer) antisense oligoneucleotide technology to the field of inhaled therapeutics. Through its collaboration with ISIS Altair has access to both near term clinical stage opportunities, as well as early stage development projects. Altair's first compound AIR645 is currently in phase I clinical trials. This first in class compound posses unique anti-inflammatory activities appropriate for multiple therapeutic applications, including asthma, rhinitis and COPD. Additionally, the characteristics of the 2'-MOE Gapmer chemistry provides for the possibility of administration of AIR645 as an inhaled therapeutic delivered once weekly. Altair is also planning on developing a future pipeline of other best-in-class molecules for respiratory targets by exploiting the advantages of its propriety 2nd generation antisense oligonucleotide chemistry. | Chief Executive Officer | 09/03/2011 |
Forward Ventures Services LLC
Forward Ventures Services LLC Investment ManagersFinance Forward Ventures Services LLC (Forward Ventures ) is a venture capital firm founded in 1990 by Standish M. Fleming and Ivor Royston. The firm is headquartered in San Diego, California. | Investment Committee Member | 31/12/2008 |
Sofinnova Investments, Inc.
Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment Inc (Sofinnova Investment) is a venture capital firm founded in 1976 by Jacques F. vallle & Joel F. Martin. The firm is headquartered in Menlo Park, California. | Chief Executive Officer | - |
Quantum Dot Corp.
Quantum Dot Corp. SemiconductorsElectronic Technology Quantum Dot Corp. develops and markets novel solutions for biomolecular detection. Its products and services employ quantum dot particles, tiny semiconductor crystals that emit light brightly in a range of sharp colors. The company was founded by Bala Manian in 1998 and is located in Hayward, CA. | Chief Executive Officer | - |
Cebix, Inc.
Cebix, Inc. Pharmaceuticals: MajorHealth Technology Cebix, Inc. provided treatments for complications of diabetes. It developed Ersatta, a proprietary disease-modifying replacement peptide for the treatment of complications associated with diabetes, including diabetic peripheral neuropathy, autonomic neuropathy, nephropathy, and retinopathy. The company was founded by John Wahren and Lars G. Ekman in 2008 and was headquartered in San Diego, CA. | Chief Executive Officer | - |
Training of Joel F. Martin
University of Michigan | Masters Business Admin |
University of California San Diego | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 12 |
---|---|
Forward Ventures Services LLC
Forward Ventures Services LLC Investment ManagersFinance Forward Ventures Services LLC (Forward Ventures ) is a venture capital firm founded in 1990 by Standish M. Fleming and Ivor Royston. The firm is headquartered in San Diego, California. | Finance |
Hypnion, Inc.
Hypnion, Inc. Miscellaneous Commercial ServicesCommercial Services Hypnion, Inc. discovered and developed neuroscience drugs. It focused on the development of novel therapeutics for the treatment of central nervous system disorders to serve the underserved markets of sleep and wake-alertness disorders and circadian rhythm abnormalities. The company was founded in 2000 and was headquartered in Lexington, MA. | Commercial Services |
Argonaut Technologies, Inc.
Argonaut Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Argonaut Technologies, Inc. develops, manufactures, and markets products that enable chemists to use high speed parallel synthesis in the development of new drugs | Commercial Services |
Institutional Venture Partners
Institutional Venture Partners Investment ManagersFinance Institutional Venture Partners (Institutional Venture Partners) is a venture capital firm founded in 1980 by Reid Dennis. The firm is headquartered in Menlo Park, California. | Finance |
Altair Therapeutics, Inc.
Altair Therapeutics, Inc. Medical DistributorsDistribution Services Altair is a privately owned company that was spun out of ISIS Pharmaceuticals in October 2007 with the objective of applying ISIS’s proprietary second generation (2’-MOE Gapmer) antisense oligoneucleotide technology to the field of inhaled therapeutics. Through its collaboration with ISIS Altair has access to both near term clinical stage opportunities, as well as early stage development projects. Altair's first compound AIR645 is currently in phase I clinical trials. This first in class compound posses unique anti-inflammatory activities appropriate for multiple therapeutic applications, including asthma, rhinitis and COPD. Additionally, the characteristics of the 2'-MOE Gapmer chemistry provides for the possibility of administration of AIR645 as an inhaled therapeutic delivered once weekly. Altair is also planning on developing a future pipeline of other best-in-class molecules for respiratory targets by exploiting the advantages of its propriety 2nd generation antisense oligonucleotide chemistry. | Distribution Services |
Cebix, Inc.
Cebix, Inc. Pharmaceuticals: MajorHealth Technology Cebix, Inc. provided treatments for complications of diabetes. It developed Ersatta, a proprietary disease-modifying replacement peptide for the treatment of complications associated with diabetes, including diabetic peripheral neuropathy, autonomic neuropathy, nephropathy, and retinopathy. The company was founded by John Wahren and Lars G. Ekman in 2008 and was headquartered in San Diego, CA. | Health Technology |
Quantum Dot Corp.
Quantum Dot Corp. SemiconductorsElectronic Technology Quantum Dot Corp. develops and markets novel solutions for biomolecular detection. Its products and services employ quantum dot particles, tiny semiconductor crystals that emit light brightly in a range of sharp colors. The company was founded by Bala Manian in 1998 and is located in Hayward, CA. | Electronic Technology |
Sofinnova Investments, Inc.
Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment Inc (Sofinnova Investment) is a venture capital firm founded in 1976 by Jacques F. vallle & Joel F. Martin. The firm is headquartered in Menlo Park, California. | Finance |
Dauntless Pharmaceuticals, Inc.
Dauntless Pharmaceuticals, Inc. Drugstore ChainsRetail Trade Dauntless Pharmaceuticals, Inc. develops specialty therapeutics via a one-asset, one-company model that is structured to facilitate operational efficiencies. The company was founded by Joel F. Martin and Michael F. Powell in May 2015 and is headquartered in San Diego, CA. | Retail Trade |
Dauntless 2, Inc.
Dauntless 2, Inc. Pharmaceuticals: MajorHealth Technology Dauntless 2, Inc. operates in the healthcare industry focused on pharmaceutical business. The company is headquartered in San Diego, CA. | Health Technology |
Dauntless 1, Inc.
Dauntless 1, Inc. Pharmaceuticals: MajorHealth Technology Dauntless 1, Inc. engages in pharmaceuticals. The company is headquartered in San Diego, CA. | Health Technology |
Intrepida Bio, Inc.
Intrepida Bio, Inc. Pharmaceuticals: MajorHealth Technology Intrepida Bio, Inc. discovers and develops medicines to modulate the innate immune system to fight cancer and other diseases. The company was founded by Joel F. Martin and Olivier Laurent and is headquartered in San Diego, CA. | Health Technology |
- Stock Market
- Insiders
- Joel F. Martin